Table 12.
Dollars | ||||||
---|---|---|---|---|---|---|
Mean | P25 | Median | P75 | P90 | P95 | |
Diabetes | ||||||
Has diabetes | 18,883 | 4,548 | 12,713 | 23,833 | 37,961 | 52,939 |
No diabetes | 18,369 | 4,566 | 12,244 | 23,120 | 37,178 | 50,841 |
Only diabetes | 17,269 | 4,417 | 12,700 | 21,500 | 34,469 | 44,438 |
Has diabetes and another diseasea | 18,348 | 5,020 | 11,790 | 23,801 | 38,112 | 46,028 |
Lung disease | ||||||
Has lung disease | 19,145 | 4,345 | 12,356 | 23,882 | 37,961 | 52,556 |
No lung disease | 18,386 | 4,588 | 12,330 | 23,132 | 37,178 | 50,841 |
Only lung disease | 16,919 | 3,984 | 12,416 | 23,520 | 35,505 | 48,704 |
Has lung disease and another diseasea | 20,563 | 4,548 | 11,965 | 23,522 | 38,512 | 57,569 |
Stroke | ||||||
Has stroke | 26,132 | 4,250 | 12,880 | 26,992 | 53,084 | 86,100 |
No stroke | 17,902 | 4,590 | 12,310 | 23,024 | 36,680 | 49,165 |
Only stroke | 27,005 | 3,380 | 12,072 | 24,890 | 41,420 | 84,784 |
Has stroke and another diseasea | 27,670 | 4,794 | 15,060 | 31,466 | 82,542 | 106,841 |
Cancer | ||||||
Has cancer | 20,709 | 5,719 | 13,729 | 25,248 | 40,179 | 57,975 |
No cancer | 18,083 | 4,400 | 13,081 | 22,842 | 36,800 | 50,841 |
Only cancer | 17,348 | 5,652 | 12,416 | 23,302 | 36,675 | 47,584 |
Has cancer and another diseasea | 23,408 | 5,800 | 14,940 | 26,500 | 45,421 | 84,942 |
Estimates of additional six‐year out‐of‐pocket medical expenditures due to disease prevalence and co‐morbidity | ||||||
---|---|---|---|---|---|---|
Mean | Quantile 25 | Quantile 50 | Quantile 75 | Quantile 90 | Quantile 95 | |
Diabetes only | –1,172 | –89 | 434 | –1,663 | –2,728 | –6,612 |
(–0.71) | (–0.14) | (0.47) | (–1.11) | (–1.09) | (–1.05) | |
Diabetes, co‐morbid | –4,630 | 50 | –1,228 | 832 | –5,203 | –20,992 |
(–1.42) | (0.04) | (–0.66) | (0.28) | (–1.04) | (–1.68) | |
Lung disease only | –1,522 | –479 | 210 | 285 | –1,842 | –2,346 |
(–0.82) | (–0.68) | (0.20) | (0.17) | (–0.65) | (–0.33) | |
Lung disease, co‐morbid | –1,501 | 375 | 652 | –2,612 | –1,907 | 4,092 |
(–0.47) | (0.31) | (0.36) | (–0.90) | (–0.39) | (0.34) | |
Stroke only | 8,564 | –1,126 | –194 | 1,727 | 4,073 | 33,734 |
(2.82) | (–0.97) | (–0.11) | (0.63) | (0.88) | (2.91) | |
Stroke, co‐morbid | 8,716 | –596 | 1,802 | 8,445 | 40,362 | 48,249 |
(2.17) | (–0.39) | (0.79) | (2.31) | (6.58) | (3.15) | |
Cancer only | –1,093 | 1,164 | 568 | 82 | –672 | –3,466 |
(–0.78) | (2.17) | (0.72) | (0.06) | (–0.31) | (–0.65) | |
Cancer, co‐morbid | 5,968 | 1,289 | 2,022 | 2,690 | 8,667 | 33,226 |
(1.88) | (1.06) | (1.12) | (0.93) | (1.78) | (2.73) | |
Constant | 18,441 | 4,506 | 12,266 | 23,163 | 37,347 | 51,050 |
(59.63) | (38.02) | (70.05) | (82.40) | (79.04) | (43.19) |
Not counting hypertension.
Note: Sample is respondents aged 60 and over in the 2002, 2004 and 2006 waves of HRS. Expenditures are for the period 2000–06. P25 is the 25th percentile, P75 is the 75th percentile and so on.(Continued)
Note: Sample is respondents aged 60 and over in the 2002, 2004 and 2006 waves of HRS. t‐statistics are shown in parentheses.